Sam Whitehouse

Sam Whitehouse has a diverse work experience spanning different industries and roles. Sam is currently serving as the Executive Chairman at High Force Research Ltd since January 2023. Prior to this, they held the position of Chief Executive Officer at the same company from January 2021 to January 2023.

Before joining High Force Research Ltd, Sam was the CEO of LIGHTOX LIMITED from January 2018 onwards. LIGHTOX LIMITED is a company that specializes in developing innovative tools for the therapeutics, diagnostics, and life science tools industries.

In addition to their roles in the private sector, Sam has also been involved in various board positions. Sam served as a Member of the Board at Medilink North of England starting from June 2018.

Sam's work in the scientific and research field includes their role as the Royal Society Entrepreneur In Residence at The Royal Society from April 2019 to December 2022. Previously, they were a Director and Chief Operating Officer at QuantuMDx Group Limited, where they played a key role in developing handheld diagnostic platforms for rapid disease diagnosis.

Earlier in their career, Sam worked as a Business Development Manager at N8 Molecular Engineering Translational Research Centre, focusing on managing scientific collaborations and securing financing for projects. Sam also gained experience as a Research Scientist at Lombard Medical Technologies plc, working on the development and commercialization of novel technologies for the cardiovascular market.

Overall, Sam Whitehouse's work experience demonstrates a strong background in leadership, business development, and scientific research across multiple industries.

Sam Whitehouse completed a PhD in Chemistry at The University of Sheffield from 2002 to 2007. Prior to that, from 1998 to 2002, they pursued an MChem degree in Chemistry at the same institution. In March 2017, Sam obtained the certification of Fellow Chartered Chemist of the Royal Society of Chemistry from the Royal Society of Chemistry.